International Conference on Atherosclerosis and Vascular Biology
(ICAVB - 26)

14th - 15th November 2026 Vancouver, Canada (Hybrid Event)

Call for Paper

The ICAVB is committed to addressing global challenges through impactful research and sustainable solutions. It brings together researchers dedicated to advancing knowledge for societal benefit. Focusing on Cardiology, the conference promotes research aligned with global development goals and long-term sustainability. Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Molecular mechanisms of atherosclerosis
  • Innovations in vascular biology research
  • Role of inflammation in atherosclerosis
  • Genetic predisposition to atherosclerotic disease
  • Impact of lifestyle on vascular health
  • Novel therapeutic targets for atherosclerosis
  • Clinical implications of atherosclerosis research
  • Role of lipids in vascular biology
  • Endothelial function and cardiovascular health
  • Emerging technologies in vascular imaging
  • Atherosclerosis in special populations
  • Patient-centered approaches to vascular health
  • Long-term outcomes of atherosclerosis treatment
  • Health disparities in atherosclerosis prevalence
  • Pharmacological advancements in vascular therapy
  • Impact of diet on atherosclerosis progression
  • Exercise and vascular health outcomes
  • Future directions in vascular biology research
  • Collaboration between basic and clinical research
  • Ethical considerations in atherosclerosis studies
Review & Publication

All submissions will be reviewed for their contribution to global impact and research quality. Accepted papers will be presented and considered for publication in reputed platforms.

Registration

Join participants from around the world by completing your registration and becoming part of a global research community.

Publication

Accepted papers will gain international exposure through conference presentations and publication opportunities.

Sponsored & Indexed by